You just read:

BioDelivery Sciences Announces Issuance of Patent in Canada Extending Exclusivity for the BEMA Technology to 2027 Covering ONSOLIS and BEMA Buprenorphine

News provided by

BioDelivery Sciences International, Inc.

Mar 21, 2011, 07:00 ET